Please provide your email address to receive an email when new articles are posted on . The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or ...
Gastropathy or gastritis? Both affect your stomach lining or mucosa. If you've received either diagnosis, it's easy to confuse the two. However, these conditions are different and affect your body in ...
The FDA has approved vonoprazan as a therapy for erosive gastroesophageal reflux disease. The phase 3 PHALCON-EE study found vonoprazan was more effective in reducing stomach acid compared to other ...
Credit: Phathom Pharmaceuticals. Voquezna, a potassium-competitive acid blocker, is supplied as 10mg and 20mg tablets. Voquezna ® (vonoprazan) is now available for the treatment of erosive esophagitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback